China NMPA Inspection - Pingyu Maya Biotechnology Co., Ltd. - July 28, 2017

The Henan Provincial Food and Drug Administration, operating under the broader regulatory authority of China's National Medical Products Administration (NMPA), published an official notice on July 28, 2017. This notice pertains to a supervision and inspection conducted at Pingyu Maya Biotechnology Co., Ltd. Designated with index number JGXX-2020-10001, the document formally announces the regulatory oversight activity involving the company. While the notice confirms the occurrence of a supervisory inspection by a provincial food and drug administration, typical of NMPA oversight processes, it does not specify the precise dates when the inspection took place. Crucially, the provided content omits details regarding any main violations, non-compliance issues, or deficiencies discovered during the inspection of Pingyu Maya Biotechnology Co., Ltd. Consequently, the document does not outline any specific required actions, corrective measures, or enforcement decisions that may have resulted from the findings. The primary function of this notice appears to be an administrative declaration of the supervision and inspection event, without publicizing its granular details or outcomes. The information available focuses on the formal announcement itself rather than the substantive findings or follow-up directives related to the company's compliance.